THESSALONIKI, Greece — March 16, 2010 — Short-term memory, as measured by immediate verbal recall, was significantly improved after treatment with a novel compound of phosphatidylserine (PS), according to data presented here on March 11 at the 25th Conference of Alzheimer’s Disease International (ADI).
This study conducted by Veronica Vakhapova, MD, Neurology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, and Amos D. Korczyn, MD, Tel Aviv University Medical School, Ramat Aviv, Israel, tested a novel preparation of PS containing omega-3 long-chain polyunsaturated fatty acids attached to its backbone (PS-DHA) to determine whether the preparation has beneficial effects on cognitive functions.
